Article (Scientific journals)
Feasibility and Acceptability of a Newborn Screening Program Using Targeted Next-Generation Sequencing in One Maternity Hospital in Southern Belgium.
Dangouloff, Tamara; Hovhannesyan, Kristine; Mashhadizadeh, Davood et al.
2024In Children, 11 (8), p. 926
Peer Reviewed verified by ORBi
 

Files


Full Text
children-11-00926-with-cover.pdf
Author postprint (377.55 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
genomic; newborn screening; targeted next-generation sequencing; treatable disease; Pediatrics, Perinatology and Child Health
Abstract :
[en] [en] PURPOSE: Genomic newborn screening programs are emerging worldwide. With the support of the local pediatric team of Liege, Belgium, we developed a panel of 405 genes that are associated with 165 early-onset, treatable diseases with the goal of creating a newborn screening test using targeted next-generation sequencing for all early-onset, treatable, and serious conditions. METHODS: A process was developed that informed the future parents about the project and collected their consent during a face-to-face discussion with a trained investigator. The first baby was screened on 1 September 2022. The main objective of the study was to test the feasibility and the acceptability of targeted sequencing at birth as a first-tier newborn screening approach to detect treatable genetic conditions or genetic conditions for which a pre-symptomatic or early symptomatic clinical trial is available. RESULTS: As of 20 June 2024, the parents of 4425 children had been offered the test; 4005 accepted (90.5%) and 420 refused (9.5%). The main reasons for refusal were the research nature of the project and the misunderstanding of what constitutes genetic conditions. CONCLUSIONS: These data demonstrate the high acceptability of genomic newborn screening in a properly informed population.
Disciplines :
Pediatrics
Author, co-author :
Dangouloff, Tamara  ;  Université de Liège - ULiège > Département des sciences cliniques
Hovhannesyan, Kristine ;  Université de Liège - ULiège > Département des sciences cliniques > Neuropédiatrie
Mashhadizadeh, Davood;  Neuromuscular Reference Center, Department of Pediatrics, University Hospital Liege, University of Liege, 4000 Liege, Belgium
MINNER, Frédéric ;  Centre Hospitalier Universitaire de Liège - CHU > > Service de pédiatrie
Mni, Myriam ;  Université de Liège - ULiège > GIGA > GIGA Medical Genomics - Unit of Animal Genomics
Helou, Laura  ;  Université de Liège - ULiège > Département des sciences cliniques
Piazzon, Flavia;  Neuromuscular Reference Center, Department of Pediatrics, University Hospital Liege, University of Liege, 4000 Liege, Belgium
Palmeira, Leonor  ;  Université de Liège - ULiège > Département des sciences cliniques
Boemer, François  ;  Université de Liège - ULiège > Département de pharmacie > Chimie médicale
Servais, Laurent  ;  Université de Liège - ULiège > Département des sciences cliniques ; MDUK Oxford Neuromuscular Centre, Department of Paediatrics, University of Oxford, Oxford OX1 3QR, UK
Language :
English
Title :
Feasibility and Acceptability of a Newborn Screening Program Using Targeted Next-Generation Sequencing in One Maternity Hospital in Southern Belgium.
Publication date :
30 July 2024
Journal title :
Children
eISSN :
2227-9067
Publisher :
Multidisciplinary Digital Publishing Institute (MDPI), Switzerland
Volume :
11
Issue :
8
Pages :
926
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
Takeda
Leon Fredericq Foundation
Sanofi
Orchard Therapeutics
Zentech
Funding text :
This work was supported by Leon Fredericq Foundation, Sanofi, Orchard Therapeutics, Takeda and, Zentech.
Available on ORBi :
since 04 January 2025

Statistics


Number of views
1 (0 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
0
Scopus citations®
without self-citations
0
OpenCitations
 
0
OpenAlex citations
 
1

Bibliography


Similar publications



Contact ORBi